| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |